APA (7th ed.) Citation

Zamanian, M., Hamadneh, L. A. Q., Veerakumarasivam, A., Abdul Rahman, S., Shohaimi, S., & Rosli, R. (2016). Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways. BioMed Central.

Chicago Style (17th ed.) Citation

Zamanian, Mohammadreza, Lama Abdel Qader Hamadneh, Abhi Veerakumarasivam, Sabariah Abdul Rahman, Shamarina Shohaimi, and Rozita Rosli. Calreticulin Mediates an Invasive Breast Cancer Phenotype Through the Transcriptional Dysregulation of P53 and MAPK Pathways. BioMed Central, 2016.

MLA (9th ed.) Citation

Zamanian, Mohammadreza, et al. Calreticulin Mediates an Invasive Breast Cancer Phenotype Through the Transcriptional Dysregulation of P53 and MAPK Pathways. BioMed Central, 2016.